Related Experiment Video
Updated: Aug 10, 2026
08:34
Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
Published on: February 24, 2021
Intervention With Autologous Platelet-Containing Plasma for Immature Atrophic Facial Scars: A Quantitative Case Study
Virgilio Blandón1, Sofia González1, Hildemar Baltodano1
1Faculty of Medicine Universidad Americana (UAM) Managua Nicaragua.
Clinical Case Reports
|August 9, 2026
Summary
Autologous platelet-containing plasma (ACP) injections improved immature atrophic scars. This minimally invasive treatment showed positive changes in scar depth, area, and texture, suggesting potential for dermal remodeling.
Area of Science:
- Dermatology
- Regenerative Medicine
- Wound Healing
Background:
- Atrophic scars present a challenge in aesthetic and reconstructive dermatology.
- Early intervention during the remodeling phase may optimize scar outcomes.
- Autologous platelet concentrates are explored for their regenerative potential.
Purpose of the Study:
- To evaluate the efficacy of intradermal autologous platelet-containing plasma (ACP) in treating immature atrophic scars.
- To assess the impact of ACP on scar depth, surface area, and texture.
Main Methods:
- Intradermal injections of ACP were administered to immature atrophic scars during the early remodeling phase.
- Scar characteristics including depth, surface area, and texture were monitored over time.
Main Results:
- Significant improvements in scar depth, surface area, and texture were observed following ACP application.
- The treatment was found to be safe and minimally invasive.
- Observed effects may potentially overlap with natural scar healing processes.
Conclusions:
- Intradermal ACP shows promise as a safe and minimally invasive treatment for immature atrophic scars.
- Further controlled studies are warranted to definitively establish the role of ACP in scar management and dermal remodeling.
